WALTHAM, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp., a privately held biopharmaceutical company, announced today that it has added two new investment groups as part of the second closing of its financing. This transaction follows the initial funding of $30 million announced on April 15, 2009. The total financing raised between the two closings is more than $33 million. The new investor groups participating in the second closing are Yasuda Enterprise Development Co., Ltd., based in Tokyo, Japan, and Hunt BioVentures, based in Dallas, Texas.
